The cannabinoid biosynthetic pathway occurs in trichomes and a main part of the pathway is linear - from hexanoate to CBG.
CBG is sometimes called the “Mother of Cannabinoids” because it is the cannabinoid from which THC, CBD, CBC and other cannabinoids are all derived.
Using non-GMO methods, that are non-proprietary, it is possible to manipulate this pathway very successfully.
Zero THC
Zero cannabinoids (perhaps the ideal variety for the hemp-derived food industry).
Higher CBG
Higher CBD
Higher CBC
Higher levels of other rare cannabinoids.
Now, developing a successful hemp variety that can be sold as seed to growers probably takes over 3 years of breeding (this is common in many crop plants).
However, if your goal is to develop a strain that makes large amounts of cannabinoids other than CBD or THC (for example CBG or CBC), then clonal production originating from a single mother plant could take as little as 18 months.
The result - differentiated products based on unique strains.
Everyone has CBD-based products but would you like CBC- or CBG-based ones?